Author:
Basta Nermine O,Halliday Gail C,Makin Guy,Birch Jillian,Feltbower Richard,Bown Nick,Elliott Martin,Moreno Lucas,Barone Giuseppe,Pearson Andrew DJ,James Peter W,Tweddle Deborah A,McNally Richard JQ
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM Children’s Oncology Group (2005) Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353: 2243–2253.
2. Bagatell R, Rumcheva P, London WB, Cohn SL, Look AT, Brodeur GM, Frantz C, Joshi V, Thorner P, Rao PV, Castleberry R, Bowman LC (2005) Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy. J Clin Oncol 23: 8819–8827.
3. Bagatell R, London WB, Wagner LM, Voss SD, Stewart CF, Maris JM, Kretschmar C, Cohn SL (2011) Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children’s Oncology Group study. J Clin Oncol 29: 208–213.
4. Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK Children’s Oncology Group (2010) Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med 363: 1313–1323.
5. Birch JM (1988) Manchester children’s tumour registry 1954–1970 and 1971–1983. In International Incidence of Childhood Cancer DM Parkin, CA Stiller, GJ Draper, CA Bieber, B Terracini, JL Young, (eds). 299–304. IARC: Lyon.
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献